昭衍新药
(603127)
| 流通市值：106.61亿 | | | 总市值：126.81亿 |
| 流通股本：6.30亿 | | | 总股本：7.50亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,862,911,984.9 | 2,904,297,343.53 | 3,040,541,368.31 | 2,964,912,277.41 |
| 应收票据及应收账款 | 212,887,775.3 | 165,057,571.87 | 169,834,960.21 | 180,104,182.43 |
| 其中：应收票据 | 6,873,300 | 9,359,690.8 | 7,267,220 | 8,890,000 |
| 应收账款 | 206,014,475.3 | 155,697,881.07 | 162,567,740.21 | 171,214,182.43 |
| 预付款项 | 110,147,213.48 | 142,061,568.19 | 69,795,420.85 | 135,744,546.66 |
| 其他应收款合计 | 11,507,653.51 | 8,678,701.05 | 8,457,197.68 | 7,720,604.68 |
| 存货 | 1,863,081,944.56 | 2,123,135,226.83 | 2,127,741,269.79 | 2,393,887,470.07 |
| 合同资产 | 127,171,761.27 | 110,636,056.21 | 104,876,831.59 | 110,065,947.53 |
| 一年内到期的非流动资产 | 1,533,490,014.42 | 1,519,865,286.18 | 21,687,739 | 21,518,326.75 |
| 其他流动资产 | 27,414,846.59 | 29,394,620.21 | 24,603,549.56 | 26,688,888.11 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,121,967,340.11 | 7,248,202,099.95 | 5,781,980,364.11 | 6,069,406,073.03 |
| 非流动资产: | | | | |
| 长期股权投资 | 19,528,685.37 | 20,044,818.77 | 20,918,911.98 | 21,827,982.57 |
| 其他权益工具投资 | 159,840,000 | 158,720,000 | 158,720,000 | 158,720,000 |
| 其他非流动金融资产 | 587,783,644.59 | 531,942,200.38 | 511,231,682.4 | 486,373,817.53 |
| 固定资产 | 583,318,976.7 | 579,783,813.05 | 586,235,461.15 | 584,202,857.81 |
| 在建工程 | 342,008,170.08 | 341,361,718.44 | 318,806,607.93 | 310,198,692.79 |
| 生产性生物资产 | 558,873,617.05 | 671,622,476.93 | 671,742,717.26 | 782,220,543.45 |
| 使用权资产 | 63,450,726.95 | 82,186,282.06 | 75,211,572.43 | 78,959,070.44 |
| 无形资产 | 292,379,829.73 | 294,234,078.1 | 297,657,957.28 | 295,653,380.2 |
| 商誉 | 136,007,078.53 | 137,871,662.28 | 138,754,987.22 | 131,955,305.39 |
| 长期待摊费用 | 74,889,044.45 | 42,493,152.56 | 45,533,685.24 | 45,391,278.91 |
| 递延所得税资产 | 28,251,272.62 | 33,266,648.57 | 33,178,685.3 | 29,501,353.31 |
| 其他非流动资产 | 58,861,244.29 | 90,941,113.44 | 1,579,337,402.75 | 1,553,673,399.85 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,905,192,290.36 | 2,984,467,964.58 | 4,437,329,670.94 | 4,478,677,682.25 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,027,159,630.47 | 10,232,670,064.53 | 10,219,310,035.05 | 10,548,083,755.28 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 43,323,313.28 | 67,945,520.71 | 49,150,088.55 | 63,928,809.79 |
| 应付账款 | 43,323,313.28 | 67,945,520.71 | 49,150,088.55 | 63,928,809.79 |
| 合同负债 | 1,151,973,539.7 | 1,370,816,837.84 | 1,394,819,974.09 | 1,462,513,246.04 |
| 应付职工薪酬 | 106,582,526.14 | 81,787,857.93 | 85,503,093.95 | 71,319,447.68 |
| 应交税费 | 44,600,630.06 | 33,768,986.43 | 27,582,486.38 | 20,531,639.36 |
| 其他应付款合计 | 88,992,348.61 | 99,767,156.87 | 312,435,732.25 | 200,017,252.79 |
| 应付股利 | - | - | 214,258,184.8 | - |
| 一年内到期的非流动负债 | 27,499,926.74 | 32,003,414.94 | 27,001,697.58 | 29,959,701.03 |
| 其他流动负债 | 4,392,804.11 | 4,262,846.44 | 3,904,152.96 | 6,274,465.84 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,467,365,088.64 | 1,690,352,621.16 | 1,900,397,225.76 | 1,854,544,562.53 |
| 非流动负债: | | | | |
| 长期借款 | - | - | - | 2,345,200.71 |
| 租赁负债 | 41,924,537.74 | 56,149,067.72 | 53,410,161.12 | 57,154,917.74 |
| 递延收益 | 74,487,463.86 | 76,875,927.91 | 78,196,448.22 | 79,247,424.33 |
| 递延所得税负债 | 162,342,125.15 | 169,145,031.89 | 163,245,811.57 | 192,645,233.21 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 278,754,126.75 | 302,170,027.52 | 294,852,420.91 | 331,392,775.99 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,746,119,215.39 | 1,992,522,648.68 | 2,195,249,646.67 | 2,185,937,338.52 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 749,888,699 | 749,888,699 | 535,678,676 | 535,678,676 |
| 资本公积 | 5,267,128,243.75 | 5,265,406,735.18 | 5,480,549,873.86 | 5,479,342,217.05 |
| 减:库存股 | 146,450,061.16 | 125,489,428.18 | 108,874,907.05 | 64,386,543.74 |
| 其他综合收益 | 100,518,137.39 | 105,741,572.74 | 108,809,501.27 | 91,154,729.97 |
| 盈余公积 | 144,259,244.76 | 119,510,687.07 | 119,510,687.07 | 119,510,687.07 |
| 未分配利润 | 2,163,971,460.61 | 2,119,325,811.56 | 1,882,340,846.2 | 2,193,731,531.76 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 8,279,315,724.35 | 8,234,384,077.37 | 8,018,014,677.35 | 8,355,031,298.11 |
| 少数股东权益 | 1,724,690.73 | 5,763,338.48 | 6,045,711.03 | 7,115,118.65 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 8,281,040,415.08 | 8,240,147,415.85 | 8,024,060,388.38 | 8,362,146,416.76 |
| 负债和股东权益合计 | 10,027,159,630.47 | 10,232,670,064.53 | 10,219,310,035.05 | 10,548,083,755.28 |
| 公告日期 | 2024-03-29 | 2023-10-31 | 2023-08-31 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |